Federal Register of Legislation - Australian Government

Primary content

PB 50 of 2011 Determinations/Health as made
This instrument amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010) which provides for price determinations in relations to brands of pharmaceutical items for which the Minister and the responsible person have not been able to make a price agreement.
Administered by: Health
Registered 27 Jul 2011
Tabling HistoryDate
Tabled HR18-Aug-2011
Tabled Senate18-Aug-2011
Date of repeal 19 Mar 2014
Repealed by Health (Spent and Redundant Instruments) Repeal Regulation 2014

PB 50 of 2011

National Health (Price and Special Patient Contribution) Amendment Determination 2011 (No. 5)1

National Health Act 1953

I, FELICITY McNEILL, Acting First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this Determination under section 85B of the National Health Act 1953.

Dated                 21 July                                 2011

 

 

 

 

FELICITY McNEILL

Acting First Assistant Secretary

Pharmaceutical Benefits Division

Department of Health and Ageing


 


1          Name of Instrument

            (1)        This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2011 (No. 5).

            (2)        This Instrument may also be cited as PB 50 of 2011.

2          Commencement

            This Instrument commences on 1 August 2011.        

3          Amendment of the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)

            Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).



Schedule 1     Amendments

 

 

[1]       Schedule 1, entry for Amoxycillin with Clavulanic Acid in the form Tablet containing 500 mg amoxycillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate)

omit from the column headed “Claimed Price”:                          5.91        substitute:             6.78

[2]       Schedule 1, entry for Amoxycillin with Clavulanic Acid in the form Tablet containing 875 mg amoxycillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate)

omit from the column headed “Claimed Price”:                          8.53        substitute:             8.78

[3]       Schedule 1, entry for Amoxycillin with Clavulanic Acid in the form Powder for oral suspension containing 125 mg amoxycillin
(as trihydrate) with 31.25 mg clavulanic acid (as potassium clavulanate) per 5 mL, 75 mL

omit from the column headed “Claimed Price”:                          4.10        substitute:             4.96

[4]       Schedule 1, entry for Amoxycillin with Clavulanic Acid in the form Powder for oral suspension containing 400 mg amoxycillin
(as trihydrate) with 57 mg clavulanic acid (as potassium clavulanate) per 5 mL, 60 mL

omit from the column headed “Claimed Price”:                          5.33        substitute:             6.20

[5]       Schedule 1, entry for Bromocriptine

omit:

 

Tablet 2.5 mg (as mesylate)

Oral

Parlodel

30

10.87

13.21

 

 

Oral

Parlodel

60

21.74

24.15

[6]       Schedule 1, entry for Escitalopram in the form Tablet 10 mg (as oxalate)

(a) omit from the column headed “Determined Price”:               18.82     substitute:             12.71

(b) omit from the column headed “Claimed Price”:                    22.90     substitute:             15.46

[7]       Schedule 1, entry for Escitalopram in the form Tablet 20 mg (as oxalate)

(a) omit from the column headed “Determined Price”:               18.93     substitute:             12.79

(b) omit from the column headed “Claimed Price”:                    24.89     substitute:             16.82

[8]       Schedule 1, entry for Felodipine in the form Tablet 2.5 mg (extended release)

(a) omit from the column headed “Determined Price”:               5.53        substitute:             5.27

(b) omit from the column headed “Claimed Price”:                    9.65        substitute:             9.39

[9]       Schedule 1, entry for Felodipine in the form Tablet 5 mg (extended release)

(a) omit from the column headed “Determined Price”:               7.89        substitute:             7.57

(b) omit from the column headed “Claimed Price”:                    12.03     substitute:             11.71

[10]     Schedule 1, entry for Felodipine in the form Tablet 10 mg (extended release)

(a) omit from the column headed “Determined Price”:               14.16     substitute:             13.70

(b) omit from the column headed “Claimed Price”:                    18.30     substitute:             17.85

[11]     Schedule 1, entry for Lamotrigine in the form Tablet 5 mg

omit from the column headed “Claimed Price”:                          9.18        substitute:             10.57

[12]     Schedule 1, entry for Lamotrigine in the form Tablet 25 mg

omit from the column headed “Claimed Price”:                          19.63     substitute:             21.03

[13]     Schedule 1, entry for Lamotrigine in the form Tablet 50 mg

omit from the column headed “Claimed Price”:                          32.40     substitute:             34.00

[14]     Schedule 1, entry for Lamotrigine in the form Tablet 100 mg

omit from the column headed “Claimed Price”:                          53.42     substitute:             54.87

[15]     Schedule 1, entry for Lamotrigine in the form Tablet 200 mg

omit from the column headed “Claimed Price”:                          89.28     substitute:             90.74

[16]     Schedule 1, entry for Lercanidipine in the form Tablet containing lercanidipine hydrochloride 10 mg

(a) omit from the column headed “Determined Price”:               8.07        substitute:             7.17

(b) omit from the column headed “Claimed Price”:                    10.94     substitute:             10.22


[17]     Schedule 1, entry for Lercanidipine in the form Tablet containing lercanidipine hydrochloride 20 mg

(a) omit from the column headed “Determined Price”:               13.48     substitute:             11.99

(b) omit from the column headed “Claimed Price”:                    16.35     substitute:             15.04

[18]     Schedule 1, entry for Meloxicam in the form Tablet 7.5 mg

(a) omit from the column headed “Determined Price”:               10.96     substitute:             9.60

(b) omit from the column headed “Claimed Price”:                    12.09     substitute:             10.59

[19]     Schedule 1, entry for Meloxicam in the form Tablet 15 mg

(a) omit from the column headed “Determined Price”:               15.99     substitute:             14.01

(b) omit from the column headed “Claimed Price”:                    17.12     substitute:             15.00

[20]     Schedule 1, entry for Methylprednisolone

(a) omit from the column headed “Determined Price”:               15.49     substitute:             13.01

(b) omit from the column headed “Claimed Price”:                    16.11     substitute:             13.53

[21]     Schedule 1, entry for Nifedipine in the form Tablet 10 mg

(a) omit from the column headed “Determined Price”:               7.80        substitute:             7.46

(b) omit from the column headed “Claimed Price”:                    8.77        substitute:             8.43

[22]     Schedule 1, entry for Nifedipine in the form Tablet 20 mg

(a) omit from the column headed “Determined Price”:               9.71        substitute:             9.18

(b) omit from the column headed “Claimed Price”:                    11.53     substitute:             11.00

[23]     Schedule 1, entry for Nifedipine in the form Tablet 20 mg (controlled release)

(a) omit from the column headed “Determined Price”:               9.68        substitute:             9.56

(b) omit from the column headed “Claimed Price”:                    11.55     substitute:             11.43

[24]     Schedule 1, entry for Nifedipine in the form Tablet 30 mg (controlled release)

(a) omit from the column headed “Determined Price”:               10.45     substitute:             10.32

(b) omit from the column headed “Claimed Price”:                    12.55     substitute:             12.42

[25]     Schedule 1, entry for Nifedipine in the form Tablet 60 mg (controlled release)

(a) omit from the column headed “Determined Price”:               13.13     substitute:             12.97

(b) omit from the column headed “Claimed Price”:                    15.45     substitute:             15.29

[26]     Schedule 1, entry for Ranitidine in the form Tablet 150 mg (as hydrochloride)

omit from the column headed “Claimed Price”:                          10.98     substitute:             11.50

[27]     Schedule 1, entry for Ranitidine in the form Tablet 300 mg (as hydrochloride)

omit from the column headed “Claimed Price”:                          10.98     substitute:             11.50

[28]     Schedule 1, entry for Salbutamol in the form Pressurised inhalation 100 micrograms (as sulfate) per dose, 200 doses
(CFC-free formulation)

(a) omit from the column headed “Determined Price”:               3.83        substitute:             3.22

(b) omit from the column headed “Claimed Price”:                    4.50        substitute:             3.78

[29]     Schedule 1, after entry for Sulfasalazine

insert in the columns in the order indicated:

Sumatriptan

Tablet 50 mg (as succinate)

Oral

Imigran

2

7.81

8.61

[30]     Schedule 1, entry for Tramadol in the form Capsule containing tramadol hydrochloride 50 mg

omit from the column headed “Claimed Price”:                          4.27        substitute:             4.36

[31]     Schedule 1, entry for Tramadol in the form Tablet (sustained release) containing tramadol hydrochloride 100 mg

omit from the column headed “Claimed Price”:                          9.87        substitute:             10.07

[32]     Schedule 1, entry for Tramadol in the form Tablet (sustained release) containing tramadol hydrochloride 150 mg

omit from the column headed “Claimed Price”:                          12.72     substitute:             12.95

[33]     Schedule 1, entry for Tramadol in the form Tablet (sustained release) containing tramadol hydrochloride 200 mg

omit from the column headed “Claimed Price”:                          15.11     substitute:             15.38

[34]     Schedule 1, entry for Valproic Acid in the form Tablet (enteric coated) containing sodium valproate 200 mg

(a) omit from the column headed “Determined Price”:               11.23     substitute:             10.22

(b) omit from the column headed “Claimed Price”:                    11.84     substitute:             10.78

[35]     Schedule 1, entry for Valproic Acid in the form Tablet (enteric coated) containing sodium valproate 500 mg

(a) omit from the column headed “Determined Price”:               22.24     substitute:             20.23

(b) omit from the column headed “Claimed Price”:                    22.90     substitute:             20.83

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1Note

All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003.  See http://www.frli.gov.au.